Skip header and navigation

Refine By

   MORE

10 records – page 1 of 1.

Access to pesticide registration data in Canada: who should know?

https://arctichealth.org/en/permalink/ahliterature235569
Source
CMAJ. 1987 Feb 15;136(4):329-32
Publication Type
Article
Date
Feb-15-1987

Canadian marketing codes: how well are they controlling pharmaceutical promotion?

https://arctichealth.org/en/permalink/ahliterature219217
Source
Int J Health Serv. 1994;24(1):91-104
Publication Type
Article
Date
1994
Author
J. Lexchin
Source
Int J Health Serv. 1994;24(1):91-104
Date
1994
Language
English
Publication Type
Article
Keywords
Advertising as Topic - legislation & jurisprudence
Canada
Drug Industry - legislation & jurisprudence
Drug Information Services - legislation & jurisprudence
Drug Prescriptions
Ethics, Pharmacy
Humans
Abstract
Pharmaceutical promotion in Canada is controlled by two codes: a voluntary one developed by the Pharmaceutical Advertising Advisory Board dealing mostly with printed promotional material, and one from the Pharmaceutical Manufacturers Association of Canada covering other forms of promotion. This article looks at enforcement of the provisions of these codes and at areas in which they are deficient. One of the major weaknesses in both codes is their lack of effective sanctions for companies that violate their provisions. Strong codes are necessary because many physicians rely heavily on promotional material for their source of prescribing information. However, voluntary codes or codes developed by the industry are inherently weak and lack effective enforcement mechanisms. Although the U.S. Food and Drug Administration is currently very active in curtailing promotional excesses, government control is not the solution since regulatory action will depend on the ideological position of the head of the regulatory body and/or the party in power. An independent body backed by legislative authority is preferable.
PubMed ID
8150569 View in PubMed
Less detail

Effect of legislative changes in drug promotion on medical students: questionnaire survey.

https://arctichealth.org/en/permalink/ahliterature153349
Source
Med Educ. 2008 Dec;42(12):1172-7
Publication Type
Article
Date
Dec-2008
Author
Lauri Vuorenkoski
Maija Valta
Otto Helve
Author Affiliation
STAKES (National Research and Development Centre for Welfare and Health), Helsinki, Finland. lauri.vuorenkoski@stakes.fi
Source
Med Educ. 2008 Dec;42(12):1172-7
Date
Dec-2008
Language
English
Publication Type
Article
Keywords
Adult
Attitude of Health Personnel
Drug Industry - legislation & jurisprudence
Drug Information Services - legislation & jurisprudence
Education, Medical, Undergraduate - methods
Female
Finland
Humans
Interprofessional Relations
Legislation, Drug
Male
Marketing - legislation & jurisprudence
Questionnaires
Students, Medical - psychology
Young Adult
Abstract
The aim of this follow-up study was to examine whether the legislative changes that took place in Finland in 2004 had an impact on the interactions between pharmaceutical companies and medical students. According to a previous survey, information provided by pharmaceutical companies represented one of the most important sources of information on pharmaceutical products for medical students and students frequently attended promotional events.
The authors collected the survey data using questionnaires distributed to medical students in Finland's five medical departments in spring 2005. A total of 1523 students (44% of all medical students in Finland) responded to the questionnaire. Results were compared with the findings of a previous study conducted in 2000.
We found a dramatic drop in how often students attended promotions given by pharmaceutical company representatives (PCRs), with 17% versus 68% of students in the clinical phase of study attending at least twice a month (P
PubMed ID
19120947 View in PubMed
Less detail

[Information hygiene and regulation of information for vulnerable groups of the population].

https://arctichealth.org/en/permalink/ahliterature263388
Source
Gig Sanit. 2014 Sep-Oct;(5):43-9
Publication Type
Article
Author
E I Denisov
A L Eremin
O V Sivochalova
N N Kurerov
Source
Gig Sanit. 2014 Sep-Oct;(5):43-9
Language
Russian
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Government Regulation
Human Rights - legislation & jurisprudence - standards
Humans
Hygiene - legislation & jurisprudence - standards
Information Services - legislation & jurisprudence - standards
Internet - legislation & jurisprudence - statistics & numerical data
Russia
Safety - legislation & jurisprudence
Vulnerable Populations - legislation & jurisprudence - psychology
Abstract
Development of information society engenders the problem of hygienic regulation of information load for the population, first of all for vulnerable groups. There are presented international and Russian normative legal documents and experience in this area, there are described the negative effects of information (such as stress, depression, suicidal ideations). There are considered social-psychological characteristics of vulnerable groups that requires their best protection from loads of information, doing harm, particularly in terms of reproductive health, family relationships, children, etc. There was noted the desirability of improvement of sanitary, legislation on the regulation of the information load on the population, especially in vulnerable groups, in terms of optimization of parameters of the signal-carriers on volume, brightness and the adequacy of the volume and content of information in radio and television broadcasting, in an urban environment and at the plant to preserve the health and well-being of the population.
PubMed ID
25831927 View in PubMed
Less detail

[Prohibited marketing and shift in meaning of indications--a case for the IGM].

https://arctichealth.org/en/permalink/ahliterature184196
Source
Lakartidningen. 2003 Jul 10;100(28-29):2378-9
Publication Type
Article
Date
Jul-10-2003

Regulating health information: the Ontario approach.

https://arctichealth.org/en/permalink/ahliterature194645
Source
Health Law Can. 2000 May;20(4):69-76
Publication Type
Article
Date
May-2000
Author
G. Sharpe
Author Affiliation
Legal Services, Ontario Ministry of Health and Long-Term Care in Toronto.
Source
Health Law Can. 2000 May;20(4):69-76
Date
May-2000
Language
English
Publication Type
Article
Keywords
Confidentiality - legislation & jurisprudence
Humans
Information Services - legislation & jurisprudence - organization & administration
Medical Records - legislation & jurisprudence
Ontario
Patient Advocacy - legislation & jurisprudence
PubMed ID
11357760 View in PubMed
Less detail

The right to know about chemical hazards in Canada, 1982-2006.

https://arctichealth.org/en/permalink/ahliterature156967
Source
New Solut. 2008;18(2):233-43
Publication Type
Article
Date
2008
Author
Dave Bennett
Author Affiliation
daveandjoanne@mts.net
Source
New Solut. 2008;18(2):233-43
Date
2008
Language
English
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Canada
Disclosure - legislation & jurisprudence
Hazardous Substances
Humans
Information Services - legislation & jurisprudence
Occupational Exposure - legislation & jurisprudence
Occupational health - legislation & jurisprudence
Abstract
Traditionally in Canada, there are three health and safety rights: the right to participate (joint workplace health and safety committees); the right to refuse unsafe and unhealthy work; and the right to know about workplace hazards. By the end of the 1970s, the right to know had been established in law across Canada, but it was not enough to cover workplace chemical hazards in particular. The Workplace Hazardous Materials Information System (WHMIS) was a project set up by the Canadian federal government in 1982 to address the issue. This article tells the story of how labor got the progressive WHMIS agreement(1985) and how the agreement has been implemented in the following years.
PubMed ID
18511399 View in PubMed
Less detail

[The last man locks and puts out the lights].

https://arctichealth.org/en/permalink/ahliterature182792
Source
Ugeskr Laeger. 2003 Oct 27;165(44):4230
Publication Type
Article
Date
Oct-27-2003

Two routes to privacy protection: a comparison of health information legislation in Canada and the United States.

https://arctichealth.org/en/permalink/ahliterature204756
Source
J Womens Health. 1998 Aug;7(6):665-72
Publication Type
Article
Date
Aug-1998
Author
S. Plater
E. Seeley
L A Dixon
Author Affiliation
Office of the Information and Privacy Commissioner of British Columbia, Victoria, Canada.
Source
J Womens Health. 1998 Aug;7(6):665-72
Date
Aug-1998
Language
English
Publication Type
Article
Keywords
Canada
Confidentiality - legislation & jurisprudence
Humans
Information Services - legislation & jurisprudence - standards
Medical Records
Public Policy
United States
Abstract
The privacy of health information is a subject of great sensitivity in both Canada and the United States. As a result of public demands for more effective protection of such information as medical records, Canada and, particularly, its provincial governments, have implemented extensive legislation. The United States, on the other hand, has largely confined its efforts to private sector initiatives that are more reflective of voluntary codes than legal statutes. Because new technologic developments facilitate data sharing in the medical field, especially in the face of a continual reduction of healthcare budgets, the concern for privacy protection in this domain has intensified. Correspondingly, there has been a gradual theoretical shift in protective health information policies on both sides of the border. As Canada pushes to extend its federal and provincial legislation to the private sector, the United States is on the brink of approving a national bill that would protect the privacy of personal medical records. It is becoming evident that efforts to secure the privacy of health information in both countries are converging.
PubMed ID
9718535 View in PubMed
Less detail

[Written drug advertisements--are they reliable?].

https://arctichealth.org/en/permalink/ahliterature169297
Source
Tidsskr Nor Laegeforen. 2006 May 11;126(10):1314-7
Publication Type
Article
Date
May-11-2006
Author
Håvard Rein Solhaug
Hanne Indermo
Lars Slørdal
Olav Spigset
Author Affiliation
Institutt for laboratoriemedisin, barne- og kvinnesykdommer, Norges teknisk-naturvitenskapelige universitet, 7489 Trondheim.
Source
Tidsskr Nor Laegeforen. 2006 May 11;126(10):1314-7
Date
May-11-2006
Language
Norwegian
Publication Type
Article
Keywords
Advertising as Topic - legislation & jurisprudence
Conflict of Interest
Drug Industry
Drug Information Services - legislation & jurisprudence - standards
Family Practice
Humans
Norway
Physician's Practice Patterns
Abstract
Drug advertisements affect the practice and continuous education of physicians. We assessed whether drug advertisements in Norway were in accordance with national regulations in the field.
All drug advertisements received by three general practitioners during a period of three months were collected. One advertisement for each of the 50 pharmaceutical products most frequently advertised was reviewed, available references obtained, and the information evaluated in relation to Norwegian regulations.
A total of 294 advertisements for 77 different products were reviewed. The 50 chosen advertisements contained 191 reference citations, of which 93% were retrieved. The originator of the advertisement in question provided 72% of the references we asked for. We identified 262 promotional claims for which the regulations require a reference citation. Of these, 135 (52%) did not comply with the regulations, including 15 (6%) that were false.
Only half of the information presented in drug advertisements was correct and clinically relevant. Relatively few statements were false, but a considerable proportion of statements gave an excessively positive picture of the product; hence, in general, this kind of information has no value as a source of information.
Notes
Comment In: Tidsskr Nor Laegeforen. 2006 Aug 10;126(15):1946; author reply 1946-716915329
PubMed ID
16691265 View in PubMed
Less detail

10 records – page 1 of 1.